The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.80
Bid: 0.75
Ask: 0.85
Change: 0.00 (0.00%)
Spread: 0.10 (13.333%)
Open: 0.80
High: 0.80
Low: 0.80
Prev. Close: 0.80
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

8 Jan 2024 16:24

RNS Number : 9988Y
N4 Pharma PLC
08 January 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BYW8QM32

Issuer Name

N4 PHARMA PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

IG Markets Limited

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

05-Jan-2024

6. Date on which Issuer notified

08-Jan-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

0.000000

3.208694

3.208694

8624339

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

 

Sub Total 8.A

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Equity swaps

Cash

8624339

3.208694

Sub Total 8.B2

8624339

3.208694%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

IG Group Holdings

IG Markets Limited

3.208694

3.208694%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

IG Markets Limited ('IGM') is a subsidiary of IG Group, the ultimate controlling person of which is IG Group Holdings plc. ('IGGH')IGM is 100% owned by IGGH through its subsidiaries, IG Group Ltd ('IGGL'), and Market Data Limited ('MDL').

12. Date of Completion

08-Jan-2024

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFLFFRLVITIIS
Date   Source Headline
2nd Nov 20172:31 pmRNSHolding(s) in Company
10th Oct 20177:00 amRNSSildenafil PCT Update
25th Sep 20177:00 amRNSInterim Results
27th Jul 20177:00 amRNSUpdate on Sildenafil clinical plans
11th Jul 201710:31 amRNSChange in Director Details
4th Jul 20177:00 amRNSFiling of Patent
30th Jun 20177:00 amRNSUpdate on Toxicity Testing of Nuvec® Particles
6th Jun 20173:06 pmRNSExercise of Warrants and Total Voting Rights
2nd Jun 20177:00 amRNSExercise of Warrants and Total Voting Rights
1st Jun 201711:02 amRNSHolding(s) in Company
31st May 20177:00 amRNSExercise of Warrants and Total Voting Rights
24th May 20173:16 pmRNSHolding(s) in Company
24th May 20173:15 pmRNSHolding(s) in Company
23rd May 201710:00 amRNSExercise of Warrants and Total Voting Rights
15th May 20174:35 pmRNSPrice Monitoring Extension
15th May 20171:50 pmRNSHolding(s) in Company
15th May 20171:50 pmRNSHolding(s) in Company
15th May 20177:00 amRNSFiling of Patents and Sildenafil Update
9th May 20173:45 pmRNSHolding(s) in Company
9th May 20173:45 pmRNSHolding(s) in Company
3rd May 20178:00 amRNSAdmission and First Day of Dealings
2nd May 20174:00 pmRNSSch 1 update - Onzima Ventures plc
2nd May 20172:06 pmRNSResult of General Meeting
18th Apr 201711:27 amRNSResult of AGM
13th Apr 20178:00 amRNSSch 1 - Onzima Ventures Plc
13th Apr 20177:00 amRNSProposed Acquisition and Capital Raising
23rd Mar 20171:03 pmRNSFinal Results for the year ended 31 December 2016
17th Jan 201710:40 amRNSProposed Acquisition, Update & Change of Adviser
11th Nov 20162:16 pmPRNInvestment Update and Change of Registered Office
17th Oct 20167:30 amRNSSuspension - Onzima Ventures plc
17th Oct 20167:00 amPRNSuspension of Trading
30th Sep 201612:19 pmRNSHalf-year Report
19th Sep 20169:22 amPRNHolding(s) in Company
6th Sep 201610:37 amPRNUpdate on Investment
19th Aug 20161:01 pmRNSResult of General Meeting
26th Jul 20161:21 pmRNSInvestment in Ferrum Crescent Limited
14th Jul 201611:45 amRNSHolding(s) in Company
12th Jul 201612:36 pmPRNInvestment
12th Jul 201611:33 amPRNHolding(s) in Company
11th Jul 201611:06 amPRNUpdate re Investment
4th Jul 20165:39 pmPRNHolding(s) in Company
4th Jul 201610:38 amPRNResult of AGM
30th Jun 20163:31 pmRNSFinal Results
23rd Jun 20167:00 amPRNIssue of Equity
14th Jun 201611:17 amPRNUpdate re Investment
13th Jun 201612:14 pmPRNHolding(s) in Company
7th Jun 20165:03 pmPRNNotice of AGM
7th Jun 20167:00 amRNSIssue of Equity
1st Jun 201611:34 amPRNHolding(s) in Company
26th May 20161:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.